(175w) Applying Engineered Microenvironments to Assess Structural and Mechanical Remodeling of the Cytoskeleton in Hypertrophic Cardiomyopathy
AIChE Annual Meeting
2024
2024 AIChE Annual Meeting
Food, Pharmaceutical & Bioengineering Division
Poster session: Engineering Fundamentals in Life Science
Monday, October 28, 2024 - 3:30pm to 5:00pm
Here, we aim to understand how a point mutation from proline to arginine at the P710 residue (P710R) in β-cardiac myosin impacts force sensitivity by leveraging the structure and molecular dynamics of vinculin, along with Forster Resonance Energy Transfer (FRET). The P710 residue is located at the proximal edge of the converter domain, which is crucial for communication between the catalytic motor and the lever arm in myosins, and thus myosinâs force-producing power stroke2. We investigate how this P710R mutation alters force dynamics at cell-cell and cell-matrix junctions and how pharmacologics affect these dynamics by studying vinculinâs force-sensitive responses. Structurally, vinculin has a globular head linked to a flexible tail by a proline-rich hinge region. It has been described as a âclutchâ system, such that when engaged, the head binds to talin, while the tail binds to a-actinin, causing it to be in an open conformation. Here, CRISPR-edited P710R hiPSC-CMs were micropatterned on polyacrylamide gel at 10 kPa, which closely mimics the physiological stiffness, to allow for the alignment of myofibrils. Our image-splitting optical system allows for high-speed ratio metric imaging for quantification of sensitive, dynamically changing protein interactions. Computational segmentation of the vinculin structures in cardiomyocytes suggests that when P710R cells are treated with mavacamten, a novel drug used to treat obstructive hypertrophic cardiomyopathy, force is reduced. Our FRET metrics suggest that altered force generation in live micropatterned P710R hiPSC-CMs affects the tension-sensing dynamics of vinculin in the myocardium. Taken together, our findings suggest that vinculin is crucial for force stabilization in HCM, and understanding its interactions with cardiac myofilament as well as other costameric proteins could elucidate its role in HCM.
- Vasile, Vlad C., et al. "A missense mutation in a ubiquitously expressed protein, vinculin, confers susceptibility to hypertrophic cardiomyopathy." Biochemical and biophysical research communications (2006)
- Vander Roest, Alison, et al. "Hypertrophic cardiomyopathy β-cardiac myosin mutation (P710R) leads to hypercontractility by disrupting super relaxed state." Proceedings of the National Academy of Sciences (2021)